Journal
MATTER
Volume 4, Issue 1, Pages 26-53Publisher
CELL PRESS
DOI: 10.1016/j.matt.2020.10.002
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [32000991, 51873150]
- Key Project of Tianjin Foundational Research (JingJinJi) Program, China [19JCZDJC64100]
Ask authors/readers for more resources
Chemotherapy is effective in treating tumors, but faces challenges such as low bioavailability and side effects. Stimuli-responsive nanomedicines activated by cascade reactions offer a solution by intensifying differences between tumor and normal tissues, leading to controlled drug release. The review highlights progress in using heat, hypoxia, and reactive oxygen species as intermediate stimuli for drug delivery.
Chemotherapy serves as one of the most effective approaches in numerous tumor treatments but also suffers from the limitations of low bioavailability and adverse side effects due to premature drug leakage. Therefore, it is crucial to realize accurate on-demand drug release for promoting the application of chemotherapeutic agents. To achieve this, stimuli-responsive nanomedicines that can be activated by delicately designed cascade reactions have been developed in recent years. In general, the nanomedicines are triggered by an internal or external stimulus, generating an intermediate stimulus at tumor site, which can intensify the differences between tumor and normal tissues; the drug release process is then further activated by the intermediate stimulus. In this review, the latest progress made in cascade reactions-driven drug-release modes, based on the intermediate stimuli of heat, hypoxia, and reactive oxygen species, is systematically summarized. The perspectives and challenges of cascade strategy for drug delivery are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available